Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Nature Protocols
|
April 2, 2011
AAV-mediated gene targeting methods for human cells
Iram F Khan, Roli K Hirata, David W Russell
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 28, 2011
Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs
David R Deyle, Iram F Khan, Gaoying Ren, et al.
Nucleic Acids Research
|
April 1, 2014
Progressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus
Yupeng Wang, Iram F Khan, Sandrine Boissel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 22, 2010
Engineering of human pluripotent stem cells by AAV-mediated gene targeting
Iram F Khan, Roli K Hirata, Pei-Rong Wang, et al.
Molecular Therapy. Methods & Clinical Development
|
January 29, 2024
Efficient and sustained <i>FOXP3</i> locus editing in hematopoietic stem cells as a therapeutic approach for IPEX syndrome
Swati Singh, Cole M Pugliano, Yuchi Honaker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 24, 2017
Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells
King L Hung, Iana Meitlis, Malika Hale, et al.
Nature Medicine
|
December 25, 2007
Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors
Thomas R Bauer, James M Allen, Mehreen Hai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 14, 2024
Targeting human plasma cells using regulated BCMA CAR T cells eliminates circulating antibodies in humanized mice
Yuchi Honaker, David Gruber, Chester Jacobs, et al.
Molecular Therapy. Methods & Clinical Development
|
March 15, 2021
Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector
Brenda J Seymour, Swati Singh, Hannah M Certo, et al.
Nature Communications
|
October 16, 2022
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
Rene Yu-Hong Cheng, King L Hung, Tingting Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Nature Protocols
|
April 2, 2011
AAV-mediated gene targeting methods for human cells
Iram F Khan, Roli K Hirata, David W Russell
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 28, 2011
Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs
David R Deyle, Iram F Khan, Gaoying Ren, et al.
Nucleic Acids Research
|
April 1, 2014
Progressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus
Yupeng Wang, Iram F Khan, Sandrine Boissel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 22, 2010
Engineering of human pluripotent stem cells by AAV-mediated gene targeting
Iram F Khan, Roli K Hirata, Pei-Rong Wang, et al.
Molecular Therapy. Methods & Clinical Development
|
January 29, 2024
Efficient and sustained <i>FOXP3</i> locus editing in hematopoietic stem cells as a therapeutic approach for IPEX syndrome
Swati Singh, Cole M Pugliano, Yuchi Honaker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 24, 2017
Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells
King L Hung, Iana Meitlis, Malika Hale, et al.
Nature Medicine
|
December 25, 2007
Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors
Thomas R Bauer, James M Allen, Mehreen Hai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 14, 2024
Targeting human plasma cells using regulated BCMA CAR T cells eliminates circulating antibodies in humanized mice
Yuchi Honaker, David Gruber, Chester Jacobs, et al.
Molecular Therapy. Methods & Clinical Development
|
March 15, 2021
Effective, safe, and sustained correction of murine XLA using a UCOE-BTK promoter-based lentiviral vector
Brenda J Seymour, Swati Singh, Hannah M Certo, et al.
Nature Communications
|
October 16, 2022
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo
Rene Yu-Hong Cheng, King L Hung, Tingting Zhang, et al.
Page
of 2